Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
about
Serum microRNA-150 predicts prognosis for early-stage non-small cell lung cancer and promotes tumor cell proliferation by targeting tumor suppressor gene SRCIN1.Identification of a protein associated with the activity of cytokine-induced killer cells.Crucial role of miR-31 in induction of CD8+ T-cell exhaustion and reinforcement of type 1 interferon signaling.Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma.MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.
P2860
Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
@en
type
label
Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
@en
prefLabel
Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
@en
P2860
P1476
Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
@en
P2093
James D Hocker
P2860
P356
10.1016/J.SMIM.2015.11.006
P577
2015-12-19T00:00:00Z